A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity

NCT06352437 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 3034701
DRUG: Placebo matching BI 3034701

Sponsor

Boehringer Ingelheim